Targeting RRM2 and Mutant BRAF is a Novel Combinatorial Strategy for Melanoma

Por Fatkhutdinov, Nail, Sproesser, Katrin, Krepler, Clemens, Liu, Qin, Brafford, Patricia A., Herlyn, Meenhard, Aird, Katherine M., Zhang, Rugang
Publicado no Mol Cancer Res (2016)

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

Por Roesch, Alexander, Fukunaga-Kalabis, Mizuho, Schmidt, Elizabeth C., Zabierowski, Susan E., Brafford, Patricia A., Vultur, Adina, Basu, Devraj, Gimotty, Phyllis, Vogt, Thomas, Herlyn, Meenhard
Publicado em 2010

PLX4032, a Potent Inhibitor of the B-Raf V600E Oncogene, Selectively Inhibits V600E-positive Melanomas

Por Lee, John T., Li, Ling, Brafford, Patricia A., van den Eijnden, Marcia, Halloran, Molly B., Sproesser, Katrin, Haass, Nikolas K., Smalley, Keiran S.M., Tsai, James, Bollag, Gideon, Herlyn, Meenhard
Publicado em 2010

Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

Por Pinnix, Chelsea C., Lee, John T., Liu, Zhao-Jun, McDaid, Ronan, Balint, Klara, Beverly, Levi J., Brafford, Patricia A., Xiao, Min, Himes, Benjamin, Zabierowski, Susan E., Yashiro-Ohtani, Yumi, Nathanson, Katherine L., Bengston, Ana, Pollock, Pamela M., Weeraratna, Ashani T., Nickoloff, Brian J., Pear, Warren S., Capobianco, Anthony J., Herlyn, Meenhard
Publicado em 2009